13D/13G Filings - Growth Equity Opportunities V LLC

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime		Transaction
Date		TypeCompany
Symbol		Filed By
Symbol		Shares Owned
% Owned		Shares Vs. Prev ReportView
2024-03-18
9:13 pm
Purchase		2024-03-1413DRegulus Therapeutics Inc.
RGLS		Growth Equity Opportunities V LLC6,533,102
9.990%		4,587,523increase
(+235.79%)		Filing
History
2023-05-12
1:57 pm
Purchase		2023-04-1313DRegulus Therapeutics Inc.
RGLS		Growth Equity Opportunities V LLC1,945,579
9.990%		487,327increase
(+33.42%)		Filing
History
2023-03-09
4:10 pm
Sale		2023-03-0913DMEI Pharma, Inc.
MEIP		Growth Equity Opportunities V LLC1
5.000%		-498,160decrease
(-100.00%)		Filing
History
2022-07-22
4:06 pm
Sale		2022-07-1113DCTI BioPharma Corp.
CTIC		Growth Equity Opportunities V LLC0
0.000%		-9,613,101decrease
(Position Closed)		Filing
History
2022-06-17
5:10 pm
Purchase		2022-06-0713DCTI BioPharma Corp.
CTIC		Growth Equity Opportunities V LLC9,613,101
8.800%		2,228,285increase
(+30.17%)		Filing
History
2021-12-09
2:58 pm
Purchase		2021-11-3013DRegulus Therapeutics Inc.
RGLS		Growth Equity Opportunities V LLC1,458,252
9.990%		1,253,007increase
(+610.49%)		Filing
History
2021-11-19
06:44 am
Sale		2021-11-1613DTrillium Therapeutics Inc.
TRIL		Growth Equity Opportunities V LLC0
0.000%		-6,586,363decrease
(Position Closed)		Filing
History
2021-08-31
6:43 pm
Unchanged		2021-08-2013DTrillium Therapeutics Inc.
TRIL		Growth Equity Opportunities V LLC6,586,363
6.300%		0
(Unchanged)		Filing
History